Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria

Onung Samuel, Akhimienho Kingsley, Amadi Collins, A. Ekanem, Umoren Ubong, Ekuma Ikwo, Asukpong Eso
{"title":"Biothesiometric Assessment of Persons Living with Diabetes Mellitus in a Tertiary Hospital in Uyo, Southern Nigeria","authors":"Onung Samuel, Akhimienho Kingsley, Amadi Collins, A. Ekanem, Umoren Ubong, Ekuma Ikwo, Asukpong Eso","doi":"10.11648/j.ijde.20230801.12","DOIUrl":null,"url":null,"abstract":": Background : The burden of foot ulceration and amputation among persons living with diabetes mellitus is quite huge and peripheral neuropathy is a well known risk factor for this. The prevalence of peripheral neuropathy and associated factors among persons living with diabetes, using an objective assessment (biothesiometer), is unknown in our study environment. Method : This was a cross-sectional study involving 108 age matched diabetes mellitus patients and controls. The study was conducted in the Diabetes Clinic of the University of Uyo Teaching Hospital, in Southern Nigeria. Basic demographics and other parameters such as duration of diabetes and glycated haemoglobin were recorded. All participants were recruited consecutively and screened for vibration perception threshold (VPT) using a biothesiometer. Participants with VPT ≥ 25 were considered to have significant neuropathy. Results : Significant neuropathy was recorded in 18 (33.3%) of the 54 diabetes patients. Only 3 (5.5%) of the 54 controls had significant neuropathy (p<0.01). The diabetes patients with significant neuropathy had a mean HbA1c of 8.9% compared to 7.3% for diabetes patients without significant neuropathy (p=0.02). The mean age of the diabetes patients with peripheral neuropathy was 54.0±2.3 years compared to 48.3±1.9 years for the diabetes patients without peripheral neuropathy (p<0.01). The mean duration of diabetes among diabetes patients with significant neuropathy was 10.3 years compared to 6.7 years for diabetes patients without significant neuropathy (p=0.01). Conclusion: There is a high prevalence of significant peripheral neuropathy among diabetes patients as determined using a biothesiometer. Early detection and achieving a good glycaemic control may help in reducing this burden which exposes the patients to the risk of possible amputation, depression and even death.","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/j.ijde.20230801.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Background : The burden of foot ulceration and amputation among persons living with diabetes mellitus is quite huge and peripheral neuropathy is a well known risk factor for this. The prevalence of peripheral neuropathy and associated factors among persons living with diabetes, using an objective assessment (biothesiometer), is unknown in our study environment. Method : This was a cross-sectional study involving 108 age matched diabetes mellitus patients and controls. The study was conducted in the Diabetes Clinic of the University of Uyo Teaching Hospital, in Southern Nigeria. Basic demographics and other parameters such as duration of diabetes and glycated haemoglobin were recorded. All participants were recruited consecutively and screened for vibration perception threshold (VPT) using a biothesiometer. Participants with VPT ≥ 25 were considered to have significant neuropathy. Results : Significant neuropathy was recorded in 18 (33.3%) of the 54 diabetes patients. Only 3 (5.5%) of the 54 controls had significant neuropathy (p<0.01). The diabetes patients with significant neuropathy had a mean HbA1c of 8.9% compared to 7.3% for diabetes patients without significant neuropathy (p=0.02). The mean age of the diabetes patients with peripheral neuropathy was 54.0±2.3 years compared to 48.3±1.9 years for the diabetes patients without peripheral neuropathy (p<0.01). The mean duration of diabetes among diabetes patients with significant neuropathy was 10.3 years compared to 6.7 years for diabetes patients without significant neuropathy (p=0.01). Conclusion: There is a high prevalence of significant peripheral neuropathy among diabetes patients as determined using a biothesiometer. Early detection and achieving a good glycaemic control may help in reducing this burden which exposes the patients to the risk of possible amputation, depression and even death.
尼日利亚南部尤约一家三级医院糖尿病患者的生物计量学评估
背景:糖尿病患者足部溃疡和截肢的负担是相当巨大的,周围神经病变是一个众所周知的危险因素。在我们的研究环境中,使用客观评估(生物测量仪),糖尿病患者周围神经病变的患病率及其相关因素尚不清楚。方法:这是一项横断面研究,涉及108例年龄匹配的糖尿病患者和对照组。这项研究是在尼日利亚南部Uyo大学教学医院的糖尿病诊所进行的。记录基本人口统计学和其他参数,如糖尿病持续时间和糖化血红蛋白。所有参与者被连续招募,并使用生物等距仪筛选振动感知阈值(VPT)。VPT≥25的参与者被认为有明显的神经病变。结果:54例糖尿病患者中有18例(33.3%)出现明显的神经病变。54例对照组中仅有3例(5.5%)有明显的神经病变(p<0.01)。有明显神经病变的糖尿病患者的平均HbA1c为8.9%,而无明显神经病变的糖尿病患者的平均HbA1c为7.3% (p=0.02)。伴有周围神经病变的糖尿病患者的平均年龄为54.0±2.3岁,无周围神经病变的糖尿病患者的平均年龄为48.3±1.9岁(p<0.01)。有明显神经病变的糖尿病患者的平均糖尿病病程为10.3年,而无明显神经病变的糖尿病患者的平均糖尿病病程为6.7年(p=0.01)。结论:糖尿病患者存在显著周围神经病变的高患病率。早期发现和实现良好的血糖控制可能有助于减轻这种使患者面临可能截肢、抑郁甚至死亡风险的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信